AI in Medicine: A New Era of Personalized Care

Transforming Cancer Care Through AI

Modern medicine has always sought to personalize treatment, but the integration of artificial intelligence marks a pivotal shift toward truly individualized care. The recent Phase 3 trial results for Moderna and Merck's mRNA-based melanoma vaccine, V940, offer a compelling example of how AI-driven approaches are transforming cancer treatment. This therapy represents a significant milestone as the first positive Phase 3 result for an individualized neoantigen therapy and the first for an mRNA-based cancer treatment.

At its core, the approach begins with analyzing a patient's tumor to identify unique mutations. An AI algorithm then selects potential targets that could help train the immune system to recognize and attack those specific cancer cells. The resulting personalized treatment encodes up to 34 neoantigens, creating what researchers call an individualized therapy.

"AI is helping us understand that each patient's cancer is unique, and our treatments should be too," said Dr. Angelos Stergiou, CEO of Sellas Life Sciences, who spoke with our team about how this technology works in practice.

The significance of these developments cannot be understated. While the initial results are promising, it's important to remember that we're still waiting for full data from the trial and FDA approval. These are early steps toward a future where treatments are not just personalized but precisely tailored to each patient's genetic makeup.

Drug Repurposing: Finding New Uses for Old Medications

Another exciting frontier is how AI is being used to repurpose existing drugs for new conditions. Dr. David Fajgenbaum and his nonprofit, Every Cure, are leading the charge in this area. Using AI to scan biomedical literature, they've identified connections between approved medications and diseases they could potentially treat.

Consider that 18,000 recognized diseases exist worldwide, yet only about 4,000 have FDA-approved treatments. This gap highlights why repurposing existing drugs is so vital. AI can generate millions of predictions in a matter of days, dramatically narrowing the search space for researchers who might otherwise spend years exploring blind alleys.

One notable example is Kaila Mabus, who was diagnosed with multicentric Castleman disease at just 13 years old. After conventional treatments failed, her doctors turned to ruxolitinib—a drug approved for blood disorders but not for Castleman disease. Within months of treatment, she showed remarkable improvement and achieved remission in early 2021.

This case illustrates why AI-driven drug repurposing is more than a theoretical concept—it's a lifeline for patients with rare or hard-to-treat conditions.

Reimagining Fertility Treatments

AI's reach extends far beyond cancer and rare diseases. In the field of fertility, researchers at Columbia University have developed STAR (Sperm Tracking and Recovery), an AI-powered system designed to identify sperm cells that conventional testing might miss. For men diagnosed with azoospermia or cryptozoospermia, this technology has opened new possibilities.

STAR combines high-speed imaging with an advanced AI model and microfluidics. It can capture and analyze about 1.1 million images per hour—far more than a human could manage. In one validation study, embryologists spent two days searching manually without finding sperm in a sample that STAR located within an hour. The system recovered 44 sperm cells, demonstrating how AI can find biological clues that would otherwise be overlooked.

The impact is not just technological—it's deeply personal. STAR helped a couple who had struggled with infertility for nearly two decades finally conceive and deliver a healthy baby in 2025. While the technology is still being refined and validated across different populations, it offers hope where traditional methods may fall short.

Early Detection of Heart Disease Risk

AI isn't just changing how we treat disease—it's also helping us predict it before symptoms appear. Researchers at the University of Hong Kong developed an AI-based tool called CardiOmicScore, which analyzes molecular data in blood samples to assess cardiovascular risk.

This system examined 2,920 circulating proteins and 168 metabolites from the UK Biobank, integrating genomic information as well. Using deep learning, it estimated future risk for six cardiovascular diseases including coronary artery disease, stroke, and heart failure. In some cases, it was able to flag elevated risk up to 15 years before symptoms would typically manifest.

Such early warning systems have profound implications for preventive medicine. Instead of waiting until a heart attack or stroke occurs, doctors could intervene earlier when lifestyle changes and treatments are most effective. However, CardiOmicScore remains experimental and is not yet available as a routine clinical screening test.

Lab-Grown Tumors: Precision in Drug Testing

At UCLA, scientists are pushing the boundaries further by developing organoids—lab-grown replicas of patient tumors. These tiny models allow researchers to test different treatments and observe how individual tumors respond to various therapies.

The process involves 3D bioprinting combined with advanced imaging and AI analysis. The AI system tracks thousands of organoids simultaneously, helping researchers understand not only which drugs work best but also how cancer cells within a tumor might behave differently under treatment.

This approach has particular value for patients with complex or aggressive cancers where traditional treatments have failed. As the technology evolves, it could eventually lead to more personalized regimens based on real-time testing of potential therapies on a patient's own tumor tissue.

The Hidden Signals in Voice and Speech

Perhaps one of the most intriguing frontiers is how AI can interpret subtle changes in speech patterns. Researchers have begun exploring voice biomarkers for neurodegenerative diseases like ALS and Parkinson's disease, where changes in speech and swallowing are early indicators.

While this field remains in its infancy, studies suggest that AI might eventually be able to detect these changes with greater sensitivity than current methods. One platform has even received FDA Breakthrough Device designation—an important step toward regulatory approval—but it hasn't yet achieved full marketing authorization.

What's clear is that AI can help doctors recognize signs of disease earlier and monitor patients more effectively, even when symptoms are not yet obvious to the human ear.

Questions for Patients and Providers

As AI becomes increasingly integrated into healthcare, understanding how these systems work is critical. Ask your doctor or provider about the following:

• What exactly does the AI system do in my care?
• Who reviews the AI's output before a decision is made?
• Is the technology FDA-approved or cleared for use?
• How is my health data used, and what safeguards are in place?

These questions help ensure that you're getting care that is both informed by cutting-edge science and guided by responsible oversight. AI isn't replacing doctors—it's enhancing their ability to make smarter decisions based on deeper insights.

The Road Ahead

The future of medicine is increasingly personalized, and artificial intelligence plays a central role in making this vision a reality. From mRNA therapies tailored to individual tumors to AI-powered fertility treatments, these innovations offer hope for patients facing some of the most challenging conditions.

But we must also remain cautious. Not all technologies are ready for widespread use. Some remain in early research phases or are available only under strict clinical supervision. As with any medical advancement, patient safety and regulatory rigor should always take precedence over excitement about potential breakthroughs.

The real test will be whether these innovations translate into better outcomes for people across the globe—improving survival rates, reducing suffering, and restoring quality of life. That's where AI can truly shine: not as a substitute for human judgment, but as a powerful tool that amplifies our collective understanding of health and healing.